MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by
degrading or repressing the translation of their target messenger RNAs. As miRNAs are …

Renal fibrosis, irrespective of its etiology, is a final common stage of almost all chronic
kidney diseases. Increased apoptosis, epithelial‐to‐mesenchymal transition, and …

Diabetic nephropathy (DN), which is a common microvascular complication with a high
incidence in diabetic patients, greatly increases the mortality of patients. With further study …

There are still major challenges regarding the early diagnosis and treatment of chronic
kidney disease (CKD), which is in part due to the fact that its pathophysiology is very …

Diabetic nephropathy (DN), one of the most common and intractable microvascular
complications of diabetes, is the main cause of terminal renal disease globally. MicroRNA …

In the last decade, miRNAs have received substantial attention as potential players of
diabetes microvascular complications, affecting the kidney, the retina, and the peripheral …

Chronic kidney disease (CKD) results in high morbidity and mortality worldwide causing a
huge socioeconomic burden. MicroRNA (miRNA) exert critical regulatory functions by …

Diabetic kidney disease (DKD) is the most common diabetic complication and is a leading
cause of end-stage kidney disease. Increasing evidence shows that DKD is regulated not …

MicroRNAs (miRNAs) are small, non-coding RNA species that control gene expression and
confer robustness to biological processes. Over the last two decades, their important roles …

Background: Diabetes Mellitus is a multifactorial disease encompassing various pathogenic
pathways. To avoid morbidity and mortality related to diabetic complications, early detection …